Pro-Dex, Inc. (PDEX)
USD 59.31
(-6.2%)
USD 59.31
(-6.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 13.54 Million USD | -8.42% |
| 2023 | 14.79 Million USD | -5.11% |
| 2022 | 15.58 Million USD | 2.54% |
| 2021 | 15.2 Million USD | 127.45% |
| 2020 | 6.68 Million USD | 46.71% |
| 2019 | 4.55 Million USD | 11012.2% |
| 2018 | 41 Thousand USD | -65.55% |
| 2017 | 119 Thousand USD | 65.28% |
| 2016 | 72 Thousand USD | -28.71% |
| 2015 | 101 Thousand USD | 573.33% |
| 2014 | 15 Thousand USD | -25.0% |
| 2013 | 20 Thousand USD | -97.42% |
| 2012 | 774 Thousand USD | -31.56% |
| 2011 | 1.13 Million USD | -60.93% |
| 2010 | 2.89 Million USD | -13.01% |
| 2009 | 3.32 Million USD | -16.51% |
| 2008 | 3.98 Million USD | 55.4% |
| 2007 | 2.56 Million USD | -25.48% |
| 2006 | 3.44 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 145 Thousand USD | -77.41% |
| 2003 | 642 Thousand USD | -34.69% |
| 2002 | 983 Thousand USD | 84.43% |
| 2001 | 533 Thousand USD | -93.02% |
| 2000 | 7.63 Million USD | -13.55% |
| 1999 | 8.83 Million USD | 17.54% |
| 1998 | 7.51 Million USD | -21.71% |
| 1997 | 9.6 Million USD | 23.08% |
| 1996 | 7.8 Million USD | 875.0% |
| 1995 | 800 Thousand USD | 0.0% |
| 1994 | 800 Thousand USD | 0.0% |
| 1993 | 800 Thousand USD | 60.0% |
| 1992 | 500 Thousand USD | -16.67% |
| 1991 | 600 Thousand USD | -14.29% |
| 1990 | 700 Thousand USD | -12.5% |
| 1989 | 800 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 13.04 Million USD | -3.32% |
| 2024 Q2 | 13.48 Million USD | 4.23% |
| 2024 Q1 | 12.94 Million USD | -12.51% |
| 2024 Q4 | 13.54 Million USD | 3.88% |
| 2024 FY | 13.54 Million USD | -8.42% |
| 2023 Q4 | 14.79 Million USD | 4.86% |
| 2023 Q3 | 14.1 Million USD | -3.05% |
| 2023 Q2 | 14.55 Million USD | -4.11% |
| 2023 Q1 | 15.17 Million USD | -2.67% |
| 2023 FY | 14.79 Million USD | -5.11% |
| 2022 Q2 | 14.4 Million USD | -2.71% |
| 2022 Q4 | 15.58 Million USD | 8.5% |
| 2022 FY | 15.58 Million USD | 2.54% |
| 2022 Q1 | 14.8 Million USD | -2.59% |
| 2022 Q3 | 14.36 Million USD | -0.27% |
| 2021 Q2 | 11.46 Million USD | 77.2% |
| 2021 Q1 | 6.46 Million USD | -3.22% |
| 2021 FY | 15.2 Million USD | 127.45% |
| 2021 Q4 | 15.2 Million USD | -0.85% |
| 2021 Q3 | 15.33 Million USD | 33.77% |
| 2020 Q1 | 7.41 Million USD | 62.73% |
| 2020 Q2 | 7.18 Million USD | -3.12% |
| 2020 Q3 | 6.94 Million USD | -3.27% |
| 2020 Q4 | 6.68 Million USD | -3.8% |
| 2020 FY | 6.68 Million USD | 46.71% |
| 2019 Q3 | 4.71 Million USD | -3.2% |
| 2019 FY | 4.55 Million USD | 11012.2% |
| 2019 Q4 | 4.55 Million USD | -3.33% |
| 2019 Q2 | 4.86 Million USD | -3.26% |
| 2019 Q1 | 5.03 Million USD | 12175.61% |
| 2018 Q3 | 50 Thousand USD | -45.05% |
| 2018 Q1 | 105 Thousand USD | -11.76% |
| 2018 FY | 41 Thousand USD | -65.55% |
| 2018 Q4 | 41 Thousand USD | -18.0% |
| 2018 Q2 | 91 Thousand USD | -13.33% |
| 2017 Q4 | 119 Thousand USD | -10.53% |
| 2017 FY | 119 Thousand USD | 65.28% |
| 2017 Q1 | 161 Thousand USD | 123.61% |
| 2017 Q2 | 148 Thousand USD | -8.07% |
| 2017 Q3 | 133 Thousand USD | -10.14% |
| 2016 FY | 72 Thousand USD | -28.71% |
| 2016 Q3 | 76 Thousand USD | -86.92% |
| 2016 Q2 | 581 Thousand USD | -2.02% |
| 2016 Q4 | 72 Thousand USD | -5.26% |
| 2016 Q1 | 593 Thousand USD | 487.13% |
| 2015 Q4 | 101 Thousand USD | -7.34% |
| 2015 FY | 101 Thousand USD | 573.33% |
| 2015 Q1 | 13 Thousand USD | -13.33% |
| 2015 Q3 | 109 Thousand USD | 808.33% |
| 2015 Q2 | 12 Thousand USD | -7.69% |
| 2014 Q3 | 16 Thousand USD | -15.79% |
| 2014 Q2 | 19 Thousand USD | -5.0% |
| 2014 FY | 15 Thousand USD | -25.0% |
| 2014 Q4 | 15 Thousand USD | -6.25% |
| 2014 Q1 | 20 Thousand USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 20 Thousand USD | -9.09% |
| 2013 FY | 20 Thousand USD | -97.42% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q3 | 22 Thousand USD | 0.0% |
| 2012 Q2 | 952 Thousand USD | -8.64% |
| 2012 Q3 | 863 Thousand USD | -9.35% |
| 2012 Q4 | 774 Thousand USD | -10.31% |
| 2012 FY | 774 Thousand USD | -31.56% |
| 2012 Q1 | 1.04 Million USD | -7.87% |
| 2011 Q4 | 1.13 Million USD | -7.3% |
| 2011 Q2 | 1.16 Million USD | -7.89% |
| 2011 Q1 | 1.26 Million USD | -56.23% |
| 2011 FY | 1.13 Million USD | -60.93% |
| 2011 Q3 | 1.22 Million USD | 4.54% |
| 2010 Q3 | 3 Million USD | -3.5% |
| 2010 Q2 | 3.11 Million USD | -3.32% |
| 2010 Q1 | 3.21 Million USD | -3.28% |
| 2010 FY | 2.89 Million USD | -13.01% |
| 2010 Q4 | 2.89 Million USD | -3.6% |
| 2009 Q3 | 3.43 Million USD | -18.47% |
| 2009 Q2 | 4.21 Million USD | -6.73% |
| 2009 Q1 | 4.51 Million USD | 13.32% |
| 2009 FY | 3.32 Million USD | -16.51% |
| 2009 Q4 | 3.32 Million USD | -3.11% |
| 2008 Q2 | 2.12 Million USD | -3.19% |
| 2008 FY | 3.98 Million USD | 55.4% |
| 2008 Q4 | 3.98 Million USD | 55.95% |
| 2008 Q1 | 2.19 Million USD | -14.39% |
| 2008 Q3 | 2.55 Million USD | 20.23% |
| 2007 Q4 | 2.56 Million USD | -27.42% |
| 2007 FY | 2.56 Million USD | -25.48% |
| 2007 Q3 | 3.53 Million USD | -1.92% |
| 2007 Q2 | 3.6 Million USD | 25.41% |
| 2007 Q1 | 2.87 Million USD | -16.53% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 FY | 3.44 Million USD | 0.0% |
| 2006 Q4 | 3.44 Million USD | -4.63% |
| 2006 Q3 | 3.6 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | - USD | -100.0% |
| 2005 Q2 | - USD | -100.0% |
| 2005 Q1 | 128 Thousand USD | -11.72% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q1 | 910 Thousand USD | 41.74% |
| 2004 Q2 | 444 Thousand USD | -51.21% |
| 2004 Q3 | 162 Thousand USD | -63.51% |
| 2004 Q4 | 145 Thousand USD | -10.49% |
| 2004 FY | 145 Thousand USD | -77.41% |
| 2003 FY | 642 Thousand USD | -34.69% |
| 2003 Q4 | 642 Thousand USD | -26.63% |
| 2003 Q3 | 875 Thousand USD | 51.38% |
| 2003 Q2 | 578 Thousand USD | 26.75% |
| 2003 Q1 | 456 Thousand USD | -53.61% |
| 2002 Q1 | 506 Thousand USD | -5.07% |
| 2002 Q2 | 518 Thousand USD | 2.37% |
| 2002 Q3 | 662 Thousand USD | 27.8% |
| 2002 Q4 | 983 Thousand USD | 48.49% |
| 2002 FY | 983 Thousand USD | 84.43% |
| 2001 Q2 | 6.64 Million USD | -8.39% |
| 2001 FY | 533 Thousand USD | -93.02% |
| 2001 Q3 | 6.16 Million USD | -7.12% |
| 2001 Q4 | 533 Thousand USD | -91.36% |
| 2001 Q1 | 7.24 Million USD | -5.08% |
| 2000 Q2 | 8.3 Million USD | -3.49% |
| 2000 Q3 | 8 Million USD | -3.52% |
| 2000 Q1 | 8.6 Million USD | -2.65% |
| 2000 FY | 7.63 Million USD | -13.55% |
| 2000 Q4 | 7.63 Million USD | -4.63% |
| 1999 Q4 | 8.83 Million USD | -5.01% |
| 1999 FY | 8.83 Million USD | 17.54% |
| 1999 Q1 | 8.1 Million USD | 7.77% |
| 1999 Q2 | 8.8 Million USD | 8.64% |
| 1999 Q3 | 9.3 Million USD | 5.68% |
| 1998 Q3 | 7.7 Million USD | 0.0% |
| 1998 Q4 | 7.51 Million USD | -2.39% |
| 1998 Q2 | 7.7 Million USD | -11.49% |
| 1998 Q1 | 8.7 Million USD | -9.38% |
| 1998 FY | 7.51 Million USD | -21.71% |
| 1997 Q2 | 9.8 Million USD | 7.69% |
| 1997 Q4 | 9.6 Million USD | -7.69% |
| 1997 Q3 | 10.4 Million USD | 6.12% |
| 1997 FY | 9.6 Million USD | 23.08% |
| 1997 Q1 | 9.1 Million USD | 16.67% |
| 1996 FY | 7.8 Million USD | 875.0% |
| 1996 Q3 | 7.9 Million USD | 1.28% |
| 1996 Q1 | 7.3 Million USD | 812.5% |
| 1996 Q2 | 7.8 Million USD | 6.85% |
| 1996 Q4 | 7.8 Million USD | -1.27% |
| 1995 Q2 | 700 Thousand USD | 0.0% |
| 1995 Q3 | 600 Thousand USD | -14.29% |
| 1995 Q4 | 800 Thousand USD | 33.33% |
| 1995 FY | 800 Thousand USD | 0.0% |
| 1995 Q1 | 700 Thousand USD | -12.5% |
| 1994 Q3 | 400 Thousand USD | -20.0% |
| 1994 Q4 | 800 Thousand USD | 100.0% |
| 1994 Q2 | 500 Thousand USD | -28.57% |
| 1994 FY | 800 Thousand USD | 0.0% |
| 1994 Q1 | 700 Thousand USD | -12.5% |
| 1993 FY | 800 Thousand USD | 60.0% |
| 1993 Q4 | 800 Thousand USD | 33.33% |
| 1993 Q3 | 600 Thousand USD | 0.0% |
| 1993 Q2 | 600 Thousand USD | 20.0% |
| 1993 Q1 | 500 Thousand USD | 0.0% |
| 1992 FY | 500 Thousand USD | -16.67% |
| 1992 Q3 | 1.3 Million USD | 0.0% |
| 1992 Q4 | 500 Thousand USD | -61.54% |
| 1991 Q4 | 600 Thousand USD | 0.0% |
| 1991 FY | 600 Thousand USD | -14.29% |
| 1990 Q4 | 700 Thousand USD | 0.0% |
| 1990 FY | 700 Thousand USD | -12.5% |
| 1989 FY | 800 Thousand USD | 0.0% |
| 1989 Q4 | 800 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | 84.194% |
| AngioDynamics, Inc. | 5.91 Million USD | -129.067% |
| AtriCure, Inc. | 74.49 Million USD | 81.815% |
| Avinger, Inc. | 15.39 Million USD | 12.004% |
| Azenta, Inc. | 60.43 Million USD | 77.585% |
| BioLife Solutions, Inc. | 42.69 Million USD | 68.267% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 99.473% |
| Daxor Corporation | 755.65 Thousand USD | -1692.74% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -88.993% |
| Femasys Inc. | 6.7 Million USD | -102.167% |
| GlucoTrack, Inc. | 196 Thousand USD | -6811.735% |
| Harvard Bioscience, Inc. | 42.77 Million USD | 68.328% |
| Hologic, Inc. | 2.53 Billion USD | 99.466% |
| ICU Medical, Inc. | 1.7 Billion USD | 99.205% |
| Intuitive Surgical, Inc. | 89.8 Million USD | 84.914% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -204.761% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | 29.055% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 98.603% |
| Microbot Medical Inc. | 231 Thousand USD | -5764.502% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -84.787% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 98.48% |
| Nephros, Inc. | 1.83 Million USD | -637.854% |
| NovoCure Limited | 596.24 Million USD | 97.728% |
| NEXGEL, Inc. | 2.79 Million USD | -384.167% |
| NEXGEL, Inc. | 2.79 Million USD | -384.167% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | 82.006% |
| OraSure Technologies, Inc. | 13.5 Million USD | -0.318% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -48.152% |
| Predictive Oncology Inc. | 2.85 Million USD | -374.2% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -294.443% |
| QuidelOrtho Corporation | 2.61 Billion USD | 99.482% |
| Repligen Corporation | 711.8 Million USD | 98.097% |
| Sanara MedTech Inc. | 11.79 Million USD | -14.882% |
| STAAR Surgical Company | 35.83 Million USD | 62.195% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -3861.111% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 99.411% |
| Jin Medical International Ltd. | 4.11 Million USD | -229.37% |